Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine Neoadjuvant Chemotherapy in Cervical Cancer
NCT02309658Phase 2Completed
- Sponsor
- IMIP
- Start
- Sep 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine in Cervical Cancer (CC), sponsored by IMIP. Started Sep 2013; status: completed.
02
Drugs
gemcitabine
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT02309658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02309658.